<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>HiF-DTA: Hierarchical Feature Learning Network for Drug-Target Affinity Prediction - Health AI Hub</title>
    <meta name="description" content="HiF-DTA is a novel hierarchical deep learning network designed to improve Drug-Target Affinity (DTA) prediction by simultaneously modeling global sequence seman">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>HiF-DTA: Hierarchical Feature Learning Network for Drug-Target Affinity Prediction</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27281v1" target="_blank">2510.27281v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Minghui Li, Yuanhang Wang, Peijin Guo, Wei Wan, Shengshan Hu, Shengqing Hu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27281v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27281v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">HiF-DTA is a novel hierarchical deep learning network designed to improve Drug-Target Affinity (DTA) prediction by simultaneously modeling global sequence semantics and local topological features from drug and protein sequences. It also represents drugs using multi-scale features (atomic, substructural, molecular) fused via bilinear attention. The model outperforms state-of-the-art baselines on benchmark datasets, confirming the importance of its global-local extraction and multi-scale fusion strategies for accelerating drug discovery.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate and efficient Drug-Target Affinity (DTA) prediction is paramount for rational drug design, significantly reducing experimental costs and accelerating the early screening phase in the discovery of new therapeutic compounds.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application described is the development of a deep learning model (HiF-DTA) to predict Drug-Target Affinity. This application significantly accelerates and de-risks the early stages of drug discovery by computationally screening potential drug candidates, thereby reducing the need for costly and time-consuming laboratory experiments. It guides the identification of promising compounds for further development, leading to new medicines for various diseases.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses limitations in sequence-based DTA prediction by concurrently extracting global sequence semantic and local topological features from drugs and proteins.</li>
                    
                    <li>Introduces a multi-scale drug representation strategy, learning distinct features at atomic, substructural, and molecular levels beyond flat sequence representations.</li>
                    
                    <li>Employs a dual-pathway network architecture to process drug and protein sequences for comprehensive feature extraction.</li>
                    
                    <li>Integrates a multi-scale bilinear attention module to effectively fuse the hierarchically learned drug representations.</li>
                    
                    <li>Achieves superior performance against state-of-the-art baseline models on key DTA prediction datasets: Davis, KIBA, and Metz.</li>
                    
                    <li>Ablation studies confirm the critical importance of both the global-local feature extraction and the multi-scale drug feature fusion mechanisms for the model's efficacy.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>HiF-DTA is a hierarchical deep learning network employing a dual-pathway strategy for drug and protein sequence processing, designed to extract both global semantic and local topological features. Concurrently, it models drugs at multiple scales‚Äîatomic, substructural, and molecular‚Äîto learn comprehensive representations. These multi-scale drug features are then fused using a multi-scale bilinear attention module, which subsequently feeds into the DTA prediction task.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>HiF-DTA consistently demonstrated superior performance compared to state-of-the-art baseline models across the Davis, KIBA, and Metz datasets. Ablation studies rigorously confirmed that both the novel global-local feature extraction from drug and protein sequences and the multi-scale fusion of drug representations are critical and indispensable components contributing to the network's enhanced DTA prediction accuracy.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research has the potential to significantly transform the initial phases of drug development by providing highly accurate computational predictions of drug-target interactions. This capability can prioritize more promising drug candidates, drastically reduce the need for extensive and expensive experimental screening, and ultimately accelerate the discovery and translation of new therapeutic agents to address various diseases, leading to more efficient and cost-effective healthcare innovations.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the proposed HiF-DTA model.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention future research directions for HiF-DTA.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug-Target Affinity</span>
                    
                    <span class="tag tag-keyword">DTA prediction</span>
                    
                    <span class="tag tag-keyword">deep learning</span>
                    
                    <span class="tag tag-keyword">hierarchical features</span>
                    
                    <span class="tag tag-keyword">multi-scale features</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">computational pharmacology</span>
                    
                    <span class="tag tag-keyword">sequence-based prediction</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Accurate prediction of Drug-Target Affinity (DTA) is crucial for reducing
experimental costs and accelerating early screening in computational drug
discovery. While sequence-based deep learning methods avoid reliance on costly
3D structures, they still overlook simultaneous modeling of global sequence
semantic features and local topological structural features within drugs and
proteins, and represent drugs as flat sequences without atomic-level,
substructural-level, and molecular-level multi-scale features. We propose
HiF-DTA, a hierarchical network that adopts a dual-pathway strategy to extract
both global sequence semantic and local topological features from drug and
protein sequences, and models drugs multi-scale to learn atomic, substructural,
and molecular representations fused via a multi-scale bilinear attention
module. Experiments on Davis, KIBA, and Metz datasets show HiF-DTA outperforms
state-of-the-art baselines, with ablations confirming the importance of
global-local extraction and multi-scale fusion.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted by International Conference on Bioinformatics and
  Biomedicine (BIBM 25)</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>